Clinical paper| Volume 177, P63-68, August 2022

Association of pulmonary hypertension with survival and neurologic outcomes in adults with in-hospital cardiac arrest



      Pulmonary hypertension (PH) has been associated with poor survival in multiple cardiopulmonary conditions, however its association with outcomes in cardiac arrest remains unknown. We aimed to evaluate the association of PH with survival and neurologic outcomes in adults with in-hospital cardiac arrest (IHCA).


      The study population included adults with IHCA undergoing resuscitation at an academic tertiary-care medical center from 2011 to 2019. Patients were classified based upon the presence versus absence of PH, defined as a pulmonary artery systolic pressure >35 mmHg on pre-arrest echocardiogram. Survival to discharge and favorable neurological outcome (defined as a Glasgow Outcome Score of 4–5) served as the primary and secondary outcomes of interest respectively.


      Of the 371 patients studied, 203 (54.7%) had PH while 168 (45.3%) did not. Patients with PH had higher Charlson Comorbidity Score with higher rates of multiple baseline comorbidities. They also had worse multi-chamber enlargement, left ventricular diastolic dysfunction, right ventricular systolic dysfunction, and valvular heart disease compared to non-PH patients. Rates of survival to discharge (11.5% vs 10.9%, p = 0.881) and favorable neurologic outcome (8.0% vs 6.2%, p = 0.550) were similar in PH and non-PH patients respectively. In multivariable analysis, PH was not associated with survival to discharge (OR 1.23, 95%CI 0.57–2.65) or favorable neurologic outcome (OR 1.69, 95%CI 0.64–4.45).


      In this contemporary registry of adults with IHCA, while PH was associated with a higher risk patient profile, it was not associated with survival or neurologic outcomes in this population.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Resuscitation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Tsao C.W.
        • Aday A.W.
        • Almarzooq Z.I.
        • et al.
        Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.
        Circulation. 2022; (Cir0000000000001052)
        • Patel J.K.
        • Meng H.
        • Parikh P.B.
        Trends in Management and Mortality in Adults Hospitalized With Cardiac Arrest in the United States.
        J Intens Care Med. 2019; 34: 252-258
        • Lowe B.S.
        • Therrien J.
        • Ionescu-Ittu R.
        • Pilote L.
        • Martucci G.
        • Marelli A.J.
        Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes.
        J Am Coll Cardiol. 2011; 58: 538-546
        • Hartopo A.B.
        • Anggrahini D.W.
        • Nurdiati D.S.
        • Emoto N.
        • Dinarti L.K.
        Severe pulmonary hypertension and reduced right ventricle systolic function associated with maternal mortality in pregnant uncorrected congenital heart diseases.
        Pulmon Circulat. 2019; 9 (2045894019884516)
        • Yigla M.
        • Fruchter O.
        • Aharonson D.
        • et al.
        Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients.
        Kidney Int. 2009; 75: 969-975
        • Reque J.
        • Quiroga B.
        • Ruiz C.
        • et al.
        Pulmonary hypertension is an independent predictor of cardiovascular events and mortality in haemodialysis patients.
        Nephrology (Carlton, Vic). 2016; 21: 321-326
        • Deferm S.
        • Bertrand P.B.
        • Yucel E.
        • et al.
        Impact of Pulmonary Hypertension on Outcomes in Patients With Mitral Annular Calcium and Associated Mitral Valve Dysfunction.
        Am J Cardiol. 2022;
        • Miceli A.
        • Varone E.
        • Gilmanov D.
        • et al.
        Impact of pulmonary hypertension on mortality after operation for isolated aortic valve stenosis.
        Int J Cardiol. 2013; 168: 3556-3559
        • Mutlak D.
        • Lessick J.
        • Carasso S.
        • et al.
        Utility of pulmonary hypertension for the prediction of heart failure following acute myocardial infarction.
        Am J Cardiol. 2012; 109: 1254-1259
        • Vanderpool R.R.
        • Saul M.
        • Nouraie M.
        • Gladwin M.T.
        • Simon M.A.
        Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.
        JAMA Cardiol. 2018; 3: 298-306
        • Jentzer J.C.
        • Wiley B.M.
        • Reddy Y.N.V.
        • Barnett C.
        • Borlaug B.A.
        • Solomon M.A.
        Epidemiology and outcomes of pulmonary hypertension in the cardiac intensive care unit.
        Eur Heart J Acute Cardiovasc Care. 2022; 11: 230-241
        • Stamm J.A.
        • McVerry B.J.
        • Mathier M.A.
        • Donahoe M.P.
        • Saul M.I.
        • Gladwin M.T.
        Doppler-defined pulmonary hypertension in medical intensive care unit patients: Retrospective investigation of risk factors and impact on mortality.
        Pulmon Circulat. 2011; 1: 95-102
        • Patel N.
        • Narasimhan B.
        • Bandyopadhyay D.
        • et al.
        Impact of Pulmonary Hypertension on In-Hospital Outcomes and 30-Day Readmissions Following Percutaneous Coronary Interventions.
        Mayo Clin Proc. 2021; 96: 2058-2066
        • Sultan I.
        • Fukui M.
        • Bianco V.
        • et al.
        Impact of Combined Pre and Postcapillary Pulmonary Hypertension on Survival after Transcatheter Aortic Valve Implantation.
        Am J Cardiol. 2020; 131: 60-66
        • Tang M.
        • Liu X.
        • Lin C.
        • et al.
        Meta-Analysis of Outcomes and Evolution of Pulmonary Hypertension Before and After Transcatheter Aortic Valve Implantation.
        Am J Cardiol. 2017; 119: 91-99
        • Kokkinidis D.G.
        • Papanastasiou C.A.
        • Jonnalagadda A.K.
        • et al.
        The predictive value of baseline pulmonary hypertension in early and long term cardiac and all-cause mortality after transcatheter aortic valve implantation for patients with severe aortic valve stenosis: A systematic review and meta-analysis.
        Cardiovasc Revasculariz Med: Includ Mol Intervent. 2018; 19: 859-867
        • Melby S.J.
        • Moon M.R.
        • Lindman B.R.
        • Bailey M.S.
        • Hill L.L.
        • Damiano Jr., R.J.
        Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis.
        J Thoracic Cardiovasc Surg. 2011; 141: 1424-1430
        • Vijayaraghavan M.
        • Prins K.W.
        • Prisco S.Z.
        • et al.
        Hemodynamic Characteristics and Outcomes of Pulmonary Hypertension in Patients Undergoing Tricuspid Valve Repair or Replacement.
        CJC Open. 2021; 3: 488-497
        • Ghoreishi M.
        • Evans C.F.
        • DeFilippi C.R.
        • et al.
        Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery.
        J Thoracic Cardiovasc Surg. 2011; 142: 1439-1452
        • Yang B.
        • DeBenedictus C.
        • Watt T.
        • et al.
        The impact of concomitant pulmonary hypertension on early and late outcomes following surgery for mitral stenosis.
        J Thoracic Cardiovasc Surg. 2016; 152: 394-400.e1
        • Crawford T.C.
        • Leary P.J.
        • Fraser 3rd, C.D.
        • et al.
        Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile.
        Chest. 2020; 157: 151-161
        • Andersen K.H.
        • Schultz H.H.
        • Nyholm B.
        • Iversen M.P.
        • Gustafsson F.
        • Carlsen J.
        Pulmonary hypertension as a risk factor of mortality after lung transplantation.
        Clin Transplant. 2016; 30: 357-364
        • Vakil K.
        • Duval S.
        • Sharma A.
        • et al.
        Impact of pre-transplant pulmonary hypertension on survival after heart transplantation: a UNOS registry analysis.
        Int J Cardiol. 2014; 176: 595-599
        • Delgado J.F.
        • Gómez-Sánchez M.A.
        • Sáenz de la Calzada C.
        • et al.
        Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation.
        J Heart Lung Transplant: Off Publ Int Soc Heart Transplant. 2001; 20: 942-948
        • Hayes Jr., D.
        • Tumin D.
        • Budev M.M.
        • Tobias J.D.
        • St John R.C.
        • Kukreja J.
        Adverse outcomes associated with pulmonary hypertension in chronic obstructive pulmonary disease after bilateral lung transplantation.
        Respir Med. 2017; 128: 102-108
        • Morgan R.W.
        • Himebauch A.S.
        • Griffis H.
        • et al.
        Pulmonary hypertension among children with in-hospital cardiac arrest: A multicenter study.
        Resuscitation. 2021; 168: 52-57
        • Morgan R.W.
        • Topjian A.A.
        • Wang Y.
        • et al.
        Prevalence and Outcomes of Pediatric In-Hospital Cardiac Arrest Associated With Pulmonary Hypertension.
        Pediatr Crit Care Med: J Soc Crit Care Med World Fed Pediatr Intens Crit Care Soc. 2020; 21: 305-313
        • Patel J.K.
        • Figueroa A.
        • Shah R.
        • Korlipara H.
        • Parikh P.B.
        Impact of right ventricular dysfunction on mortality in adults with cardiac arrest undergoing coronary angiogram.
        Resuscitation. 2019; 137: 229-233
        • Patel J.K.
        • Schoenfeld E.
        • Hou W.
        • et al.
        Inhaled nitric oxide in adults with in-hospital cardiac arrest: A feasibility study.
        Nitric Oxide: Biol Chem. 2021; 115: 30-33
        • Gibbs J.S.
        • Keegan J.
        • Wright C.
        • Fox K.M.
        • Poole-Wilson P.A.
        Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure.
        J Am Coll Cardiol. 1990; 15: 52-61
        • Bidart C.M.
        • Abbas A.E.
        • Parish J.M.
        • Chaliki H.P.
        • Moreno C.A.
        • Lester S.J.
        The noninvasive evaluation of exercise-induced changes in pulmonary artery pressure and pulmonary vascular resistance.
        J Am Soc Echocardiogr: Off Publ Am Soc Echocardiogr. 2007; 20: 270-275
        • Sreter K.B.
        • Budimir I.
        • Golub A.
        • Dorosulić Z.
        • Sabol Pušić M.
        • Boban M.
        Changes in pulmonary artery systolic pressure correlate with radiographic severity and peripheral oxygenation in adults with community-acquired pneumonia.
        J Clin Ultrasound: JCU. 2018; 46: 41-47
        • Faggiano P.
        • D'Aloia A.
        • Gualeni A.
        • Ambrosino N.
        • Pagani M.
        • Giordano A.
        Dobutamine-induced changes in pulmonary artery pressure in patients with congestive heart failure and their relation to abnormalities of lung diffusing capacity.
        Am J Cardiol. 1998; 82 (1296–8 a10)